High Purity Peramivir Impurity CAS 316173-29-2

• Powder: Yes
• Customized: Non-Customized
• Certification: HSE, USP, BP
• Suitable for: Elderly, Adult
• State: Solid
• Purity: >98%
• Model NO.: jf01
• Effect: Antidepressent
• Assay: 99.1%
• Annul Sales: 2000kg
• Package: Drums
• Residual Solvent: Ethanol
• Sample: Free
• Heavy Metal: 10ppm
• Capacity: 2500kg
• Keyword: Tartaric Acid
• Residual Solvents: 20ppm
• Stock: 2000kgs
• Other Name: Peramivir Impurity
• Usage: Cometics Powder
• Skin: Whitening
• GMP: Yes
• Transport Package: Drun
• Specification: ip
• Trademark: jf
• Origin: China
• HS Code: 2099055900
• Production Capacity: 2800

Product Description

Peramivir  CAS 229614-55-5


RAPIVAB injection is a clear, colorless, sterile, isotonic solution (200 mg per 20 mL) in glass vials fitted with rubber stoppers and royal blue flip-off seals. Each mL contains 10 mg peramivir (on an anhydrous basis) in 0.9% sodium chloride solution. The pH may have been adjusted with sodium , USP and/or hydrochl acid, USP. The pH is 5.5 - 8.5.

Peramivir is an antiviral agent developed by Biocryst Pharmaceuticals to treat influenza A/B. The development of peramivir has been supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic. Being an influenza virus neuraminidase inhibitor, peramivir works by preventing new viruses from emerging from infected cells. Due to the poor oral bioavailability, the oral formulation of the drug was previously abandoned by Johnson and Johnson Company. The injectable intravenous formulation of peramivir was approved by the FDA in September 2017 for the treatment of acute uncomplicated influenza to pediatric patients 2 years and older who have been symptomatic for no more than two days.